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1. Introduction  
 
Stem cells have self-renewing capacity and are able to 
differentiate into single or multiple types of specialized stem 
cells. MSCs are the stem cells which are most widely used for 
various therapeutic purposes due to their ease of isolation from 
the organs and tissues where they reside[1]. Bone marrow, 
umbilical cord and adipose tissue are the main sources of 
MSCs. The stem cells that are derived from human adipose 
tissue are known as adipose-derived stem cells (ASCs), which 
have a similar phenotype and morphology as bone marrow-
derived MSCs[2]. ASCs are mostly obtained from liposuction 
procedures and also from tissue resected from the subcutaneous 
and visceral fat depots of white adipose tissue (WAT). ASCs 
from different origins have distinct inherent properties[3, 4]. The 
acquisition of tissue is less complex and the cells are more 
abundant for ASCs than for bone marrow-derived MSCs. 
Because of their high proliferative and differentiative 
capacities, ASCs are capable of repairing vital tissues and 
organs, thereby replacing lost soft tissues. All of these 
remarkable properties make ASCs as the most promising cell 
type for tissue engineering and regenerative medicine[1, 5, 6].  
 
ASCs from subcutaneous adipose tissue were used in the 
present study. The selection of an artificial skin substitute is 
equally as important as the selection of an appropriate cell line 
because the success rate of the repair process depends on the 
interaction between the scaffold  used  and the selected cell line 
R E S E A R C H   A R T I C L E 
JSRM/Vol.12 No.2, 2016; P79  
JSRM Code: 012020300012 
Gomathysankar S1, Halim AS1, Yaacob NS2, Noor NM1, Mohamed M1 
 Adipose-derived stem cells (ASCs) have potential applications in the repair and regeneration of various tissues and organs. The use of 
various scaffold materials as an excellent template for mimicking the extracellular matrix to induce the attachment and proliferation of 
different cell types has always been of interest in the field of tissue engineering because ideal biomaterials are in great demand. Chitosan, a 
marine polysaccharide, have wide clinical applications and it acts as a promising scaffold for cell migration and proliferation. ASCs, with 
their multi-differentiation potential, and chitosan, with its great biocompatibility with ASCs, were investigated in the present study.  
 
ASCs were isolated and were characterized by two different methods: immunocytochemistry and flow cytometry, using the mesenchymal 
stem cell markers CD90, CD105, CD73 and CD29. The ASCs were then induced to differentiate into adipogenic, osteogenic and 
chondrogenic lineages. These ASCs were incorporated into a porous chitosan scaffold (PCS), and their structural morphology was studied 
using a scanning electron microscope and hematoxylin and eosin staining. The proliferation rate of the ASCs on the PCS was assessed using 
a PrestoBlue viability assay.  
 
The results indicated that the PCS provides an excellent template for the adhesion and proliferation of ASCs. Thus, this study revealed that 
PCS is a promising biomaterial for inducing the proliferation of ASCs, which could lead to successful tissue reconstruction in the field of 
tissue engineering. 
 
 
that is seeded on the scaffold. Recently, researchers have shown 
intensified interest in seeding stem cells on tissue-engineered 
scaffolds[7-9]. Due to the various limitations of skin grafts and 
artificial implants, the purpose of developing biological 
substitutes or 3D scaffolds incorporating appropriate cell lines is 
better restoration of tissue function[10, 11]. Because ASCs are easy 
to isolate and are abundantly available, they are the stem cells 
most commonly seeded on various biomaterials to study the 
efficacy of stem cells in repairing damaged tissues[12]. 
 
There is a wide range of natural and synthetic polymers available 
for use as scaffold materials. Selecting the appropriate biomaterial 
among these various types of biopolymers is crucial[13]. The 
combination of ASCs with appropriate biomaterials or skin 
substitutes is promising in the regeneration of damaged tissues. 
Several of the naturally derived biomaterials used for fat tissue 
engineering include Matrigel, collagen type I matrix, a collagen-
chitosan blend, and collagen sponges, and several of the synthetic 
biomaterials used for fat tissue engineering include polyglycolide 
(PGA) scaffolds, poly(ethylene glycol)-based hydrogel and 
perfluoroelastomer[14]. Natural biomaterials are widely preferred 
because of their biocompatible and biodegradable nature. 
 
Currently, chitosan, a marine polysaccharide, is the most widely 
used biopolymer in various biomedical applications because of its 
potential in stimulating hemostasis and accelerating the 
regeneration of damaged or lost tissues in the process of wound 
healing[15].  Naturally   obtained  chitosan  biomaterials  are  more  
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biocompatible and biodegradable than synthetic materials[16-18]. 
Chitosan-based biomaterials have now been of major interest because 
of their anti-microbial, nontoxic, renewable, bio absorbable and 
biopolymer properties. Chitosan is a cationic amino polysaccharide 
which exhibits a stronger adherence to the tissues at the site of wound 
that are anionic. Various types of chitosan biomaterials in the forms of 
hydrogel, pastes, powders, sheets, sponges and porous scaffolds are 
produced using different processing methods[19]. Therefore, surface 
modification of chitosan scaffolds to increase the biofunctionality, is 
an effective approach in clinical applications. Chitosan can be 
fabricated into a stable, porous scaffold and hence, numerous 
populations of cultured cells could be seeded onto these scaffolds. 
Tissue-engineered porous chitosan scaffolds (PCSs) act as an artificial 
extracellular matrix (ECM) that lays the foundation for cell 
attachment, cell proliferation, cell differentiation and the migration of 
cells to the desired site to repair damaged tissues. Porous chitosan 
skin-regenerating templates have been found to be a more 
biocompatible wound dressing due to their stimulation of cell 
proliferation[18, 20]. This study highlights the structural morphology 
and proliferative capacity of ASCs seeded on the customized PCSs.  
 
2. Materials and methods 
2.1 Biomaterial 
The PCSs used in this research were customized and produced by the 
Advanced Materials Research Centre, Standards and Industrial 
Research Institute of Malaysia (SIRIM). The procedure for preparing 
chitosan was mentioned previously[21]. Briefly, Ultrapure and 
medical-grade chitosan were produced from prawn shell. Chitosan 
powder with molecular weight of 634 kDa and a degree of 
deacetylation of 89% was purchased from Hunza Nutriceuticals, 
Malaysia. 2% (w/v) of chitosan solution was prepared by dissolving 
chitosan powder in 1% (v/v) reconstituted acetic acid. The pH of 
chitosan solution was adjusted to 6.2 by adding 0.2 M sodium 
bicarbonate. Porous chitosan scaffolds were prepared by freeze-drying 
technique whereby chitosan solution was poured into graded porous 
mould and cooled to -20°C before   lyophilization for 24 h. They were 
sterilized by ethylene oxide gas and stored at room temperature, in the 
dark and dry place. The PCSs were characterized and analyzed by 
scanning electron microscopy (SEM) and Fourier transform infrared 
(FTIR) spectroscopy, as described in a previous article[22]. 
 
2.2 Isolation and culture of Adipose-Derived Stem Cells  
 
Adipose tissue samples were obtained from subcutaneous adipose 
tissue resected from patients with informed written consent. Ethical 
clearance was obtained from the Human Ethics Committee of 
Universiti Sains Malaysia (Reference no.: USMKK/PPP/JEPeM 
[236.3(16)]). The samples were processed within 24 hrs. Each tissue 
sample was washed several times with Dulbecco’s phosphate-
buffered saline (DPBS) (Gibco, USA) containing 1% (v/v) antibiotic-
antimycotic (Gibco, USA) to remove any blood from the resected 
tissue. The tissue was then chopped finely with sterile scissors and 
enzymatically dissociated by the addition of 0.1% (w/v) collagenase 
type I (Worthington, USA), followed by overnight incubation at 
37°C. The next day, the enzymatically dissociated tissue was passed 
through a 70 µm cell strainer to remove the remaining undissociated 
tissue, neutralized by the addition of DPBS and centrifuged at 800 x g 
for 5 min. The obtained stromal cell pellet was resuspended in 
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, USA) 
containing 10% MSC-qualified fetal bovine serum (FBS) (Gibco, 
Mexico) and 1% antibiotic-antimycotic solution. The cells were 
cultured in T25 flasks and maintained in a 5% carbon dioxide (CO2) 
incubator at 37°C. Once the primary cultures reached 80% 
confluence, further passages were obtained by detaching the cells 
from  the  flasks  using  TrypLE Express  (Gibco, USA).  Ten minutes  
after   the   addition   of   TrypLE   Express,  the  detached  cells  
were neutralized by adding DMEM and were centrifuged at 800 x g 
for 5 min. The obtained stromal cell pellet was resuspended in 
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, USA) 
containing 10% MSC-qualified fetal bovine serum (FBS) (Gibco, 
Mexico) and 1% antibiotic-antimycotic solution. The cells were 
cultured in T25 flasks maintained in a 5% carbon dioxide (CO2) 
incubator at 37°C. Once the primary cultures reached 80% 
confluence, further passages were obtained by detaching the cells 
from the flasks using TrypLE Express (Gibco, USA). Ten minutes 
after the addition of TrypLE Express, the detached cells were 
neutralized by adding DMEM and were centrifuged at 800 x g for 5 
min. The obtained cell pellet was then resuspended in DMEM and 
cultured in new T25 flasks. The ASCs were maintained in 
MesenPRO RS Medium (Gibco, USA), which is specifically 
formulated for the growth of MSCs used from passage 3 onward. 
ASC cultures at passages 3-6 were used throughout the experiments. 
 
2.3 Characterization of Adipose-Derived Stem Cells  
 
2.3.1 Immunocytochemistry (ICC) analysis 
 
The experiment was performed using an IHC Select® HRP/DAB 
Test (Chemicon, USA). Cells were cultured on a 24-well plate at a 
seeding density of 1 x 106/ml. Within the next two days, the ASCs 
reached 80% confluence, and the staining was performed. The cells 
were washed with DPBS twice and were fixed with cold methanol 
for 15 min at 4°C. The non-specific binding sites on the cells were 
blocked with goat serum for 10 min. Primary antibodies, with an 
optimized dilution ratio of 1:500, were added to the cells and 
incubated for 1 hr at room temperature (RT). The primary antibodies 
that were used to stain the ASCs were mouse anti-human 
immunoglobulin G1 (IgG1) monoclonal antibodies against CD29 
(Clone 12G10, Abcam, UK), CD105 (Clone SN6, Abcam UK), 
CD73 (Clone AD2, BD Pharmingen, NJ) and CD90 (Clone 5E10, 
BD Pharmingen, NJ). Mouse IgG1 (1:500) (Abcam, UK) was used as 
the negative control. The cells were washed using washing buffer 
and were incubated with secondary antibody (biotinylated goat anti-
mouse IgG) for 10 min. Streptavidin-horseradish peroxidase (HRP) 
was then added to bind to the biotin-labeled secondary antibody for 
10 min of further incubation. After the addition of the streptavidin-
HRP, the cells were washed with washing buffer and stained with 
chromogenic reagent to label cells that were positive for the above-
mentioned markers for 10 min. Finally, the cells were counterstained 
with hematoxylin solution for 1 min, washed with washing buffer 
and analyzed under an inverted phase-contrast microscope (Zeiss, 
Germany). All of the reagents except for the primary antibodies were 
provided in the kit (the IHC Select® HRP/DAB Test). 
 
2.3.2 Flow cytometry analysis 
 
Surface marker staining was performed for flow cytometry analysis. 
Cells were detached from their flask using TrypLE Express, 
resuspended at a concentration of 1 x 106/ml and stained with 
primary antibodies for 1 hr. The primary antibodies used were the 
same antibodies as those used for the ICC analysis, but with different 
dilutions: mouse anti-human IgG1 monoclonal antibodies against 
CD90 (1:100), CD29 (1:50), CD73 (1:50), and CD105 (1:10). 
Purified mouse IgG1, k (1:1000) (Clone MOPC-21, BD Pharmingen, 
NJ) was used as an isotype control. An antibody against the 
hematopoietic stem cell marker CD34, or PE mouse anti-human 
CD34 (1:100) (Clone 563, BD Pharmingen, NJ), was used as a 
negative control. The cells were then washed with DPBS and 
centrifuged at 800 x g for 5 min. Next, all cells except the negative-
control cells were stained with FITC-conjugated goat polyclonal 
secondary antibody to mouse IgG H&L (1:1000) (Abcam, UK) for   
30-40   min   at   RT.  The  cells  were  then  analyzed  using  a  flow  
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cytometer (FACSCanto II, BD Biosciences, USA). The data 
acquisition and interpretation were performed using BD FACSDiva 
software.  
 
2.4 Induced cell differentiation 
 
2.4.1 Detection of lipids 
 
ASCs at passage 4 were cultured at a seeding density of 1 x 105/well 
in a six-well plate. The ASCs were maintained in MesenPRO RS 
Medium until the cells reached 80% confluence. The StemPro 
Adipogenesis Differentiation Kit (Gibco, USA) was used to induce 
the ASCs to differentiate into adipocytes. The cells were maintained 
in adipogenic differentiation medium for 14 days, during which the 
medium was changed every 3 days. The control groups were 
maintained in adipogenic differentiation medium for 3 days, and after 
that, MesenPRO Medium was used. The differentiation was 
confirmed using Oil Red O staining. Briefly, the differentiated cells 
were removed from the incubator after 14 days and were washed with 
DPBS. After the DPBS was removed, the cells were fixed with 10% 
neutral buffered formalin for 1 hr at RT. The formalin was then 
removed from each well, and the cells were washed with deionized 
(DI) water. Next, 60% isopropanol was added to each well and 
incubated at RT for 10 min to extract the lipids from the adipose cells. 
Once the isopropanol was removed, and Oil Red O staining solution 
(Sigma, USA) was added and incubated for 10 min at RT. The cells 
were then washed several times with DI water until the Oil Red O 
stain was completely removed. The cells were counterstained by 
adding hematoxylin solution for 1 min, after which the hematoxylin 
was removed and the cells were washed with DI water.  
Approximately 1 ml of DI water was finally added to cover the entire 
cell monolayer, and images were then captured using an inverted 
phase-contrast microscope.  
 
2.4.2 Osteoblast detection 
 
ASCs at passage 4 were cultured at a seeding density of 1 x 105/well 
in a six-well plate. The ASCs were maintained in MesenPRO RS 
Medium until the cells reached 80% confluence. The StemPro 
Osteogenesis Differentiation Kit (Gibco, USA) was used to induce the 
ASCs to differentiate into osteoblasts. The cells were maintained in 
osteogenic differentiation medium for 21 days, during which the 
medium was changed every 3 days. When the differentiated cells 
were removed from the incubator after 21 days, the differentiation 
was confirmed by Alizarin Red S staining and alkaline phosphatase 
(AP) staining. For the Alizarin Red S staining, the differentiated cells 
were washed with DPBS, fixed with 10% neutral buffered formalin 
for 1 hr, stained with Alizarin Red S staining solution (Millipore, 
USA) in the dark for 45 min at RT and analyzed using an inverted 
phase-contrast microscope. For the AP staining, the differentiated 
cells were washed with DPBS and fixed with 10% formalin for less 
than 1 min because a longer incubation would inactivate AP. The cells 
were then stained with 5-bromo-4-chloro-3-indolyl-phosphate with 
nitro blue tetrazolium (BCIP/NBT) substrate solution (Sigma-Aldrich, 
USA) at RT in the dark for 5-10 min and washed with DI water, after 
which images were observed using an inverted microscope. 
 
2.4.3 Detection of cartilage extracellular matrix 
 
The ASCs at passage 4 were cultured at a seeding density of                    
1 x 105/well in a six well plate. The ASCs were maintained in 
MesenPRO RS Medium until the cells reached 80% confluence. The 
StemPro Chondrogenesis Differentiation Kit (Gibco, USA) was used 
to induce the ASCs to differentiate into cartilage spheroids. The ASCs 
were maintained in the chondrogenesis differentiation medium for 14 
days, during  which  the  medium  was  changed  every 3 days.  When  
the differentiated cells were removed from the incubator after 14 
days, they were washed with DPBS. The cells were then fixed with 
10% formalin for 1 hr. After that, the cells were washed with DI 
water and stained with 2 ml of Alcian-Blue staining solution 
(Millipore, USA) overnight at RT in the dark. On the subsequent day, 
the staining solution was removed, and the cells were washed with 
destaining solution (ethanol (98-100%): acetic acid (98-100%) at a 
dilution ratio of 3:2) for 20 min. The destaining solution was 
removed, and DPBS was added to cover the cell monolayer, after 
which images were observed using an inverted phase-contrast 
microscope. 
 
2.5 Incorporation of ASCs into PCSs and cell viability assessment 
 
Chitosan discs that were 2 mm thick and 5 mm in diameter were 
used. The PCSs were placed on 24-well plates, and wells with only 
ASCs were used as a control. ASCs at passage 4 were seeded on the 
PCSs at a density of 2x106/ml. The viability assay was performed 
from days 1-7. The cells were incubated with PrestoBlue cell 
viability reagent (Invitrogen, USA) at a dilution ratio of 1:10 for 24 
hrs, and then the supernatant was transferred to a 96-well plate and 
analyzed using the Infinite 200 PRO NanoQuant enzyme-linked 
immunosorbent assay (ELISA) reader (Tecan, Austria). The 
absorbance was determined at 570 nm, with a reference wavelength 
of 600 nm. 
 
2.6 Morphological analysis  
 
2.6.1 Scanning electron microscopy  
 
Following the seeding of ASCs on the chitosan scaffolds for 1, 3 or 7 
days, the PCSs were washed and fixed with 2.5% glutaraldehyde for 
1 hr. The scaffolds were then washed and dehydrated using a graded 
alcohol series with dilutions of 30%, 70% and 100% ethanol. SEM 
(FEI Quanta 450 FEG, Netherlands) was used to observe the 
morphology of the ASCs attached to the PCSs. 
 
2.6.2 Hematoxylin and Eosin (H&E) staining 
 
The interaction of ASCs with the PCSs were further analyzed using 
H&E staining. On day 7, the PCSs seeded with ASCs were washed 
and fixed with 10% formalin, embedded in paraffin and sectioned at 
a 4 µm thickness. H&E staining was then performed as follows. 
Sections of scaffold seeded with ASCs were carefully transferred to 
dry slides. The slides were washed in xylene to remove the paraffin. 
The slides were then sequentially washed in 100%, 95%, 80% and 
70% ethanol for 5 min each to remove the xylene. Next, the slides 
were rinsed in tap water for 5 min to remove the ethanol and 
immersed in hematoxylin for 15 min to stain the cell nuclei. 
Following the hematoxylin staining, the slides were washed in 1% 
acid alcohol for 5 secs and in running tap water for 5 min to remove 
the excess stain. The slides were then dipped in ammonia for 5 secs 
to neutralize the reactivity of the acid alcohol, followed by washing 
in running tap water for 5 min and immersion in eosin for 5 min to 
stain the cytoplasm. Finally, the slides were sequentially washed in 
100%, 95%, 80% and 70% ethanol for 5 min each and in xylene for 3 
min. Coverslips were then mounted onto the slides. Images were 
observed using Mirax Desk scanner (Zeiss, Germany). 
 
2.7 Statistical analysis 
 
Statistical analysis was performed using SPSS software, version 21. 
All values are presented as the mean ± standard error of the mean. 
Statistical analysis were done using Kruskal-Wallis test with n=4 and 
p<0.05 was considered to indicate a statistically significant 
difference. 
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3. Results 
 
3.1 ICC characterization of ASCs using selective markers 
 
Characterization of the human ASCs was performed using ICC. The 
cells were stained and found to be positive for the cell surface markers 
CD29, CD90, CD105 and CD73, as shown in Figure 1. ASCs have 
spindle shape like morphology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2 Flow cytometry analysis of ASCs 
 
Flow cytometry analysis of the human ASCs confirmed the cells’ 
expression of the cell surface markers CD90, CD73, CD29, and 
CD105. The ASCs were found to be negative for the hematopoietic 
stem marker CD34. These characterized human ASCs were fully 
capable of differentiating into adipogenic, osteogenic and 
chondrogenic cell lineages. The samples were analyzed by flow 
cytometry with at least 10000 events detected, excluding cell debris 
and aggregates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Induced differentiation of ASCs into adipocytes, osteoblasts and 
chondrogenic matrix 
 
The induced differentiation of the ASCs into adipocytes, 
chondrocytes and osteoblasts is shown in Figure 4. In figure 4A and 
4B, adipogenic differentiation was observed at 2 weeks after 
induction, and the differentiation was confirmed using Oil Red O 
staining. The staining clearly revealed the presence of lipid droplets 
in the differentiated adipocytes. Alizarin Red S staining and AP 
staining were performed to confirm calcium deposition and 
osteoblast formation upon osteogenic induction. While staining the 
calcium deposits with Alizarin Red S, (Figure 4C) the 
undifferentiated ASCs without extracellular calcium deposits 
appeared slightly reddish at 2 weeks of induction, whereas (Figure 
4D) the ASCs that fully differentiated into osteoblasts appeared 
bright orange-red in color at 4 weeks of induction. While staining the 
osteoblasts with AP, (Figure 4E) the undifferentiated ASCs, showing 
weak AP activity, appeared faintly bluish in color after 2 weeks of 
induction, whereas (Figure 4F) the fully differentiated osteoblasts, 
with high AP activity, appeared dark blue-violet or nearly black in 
color after 4 weeks of induction. Finally, chondrogenic 
differentiation of the ASCs was confirmed using Alcian-Blue 
staining. The cartilage ECM appeared dark-blue (Figure 4G) at 2 
weeks and (Figure 4H) at 4 weeks after induction.   
 
3.4 Proliferation rate of ASCs on PCSs 
 
The data obtained from the quantitative analysis of the PrestoBlue 
viability assay is shown in the table (Table 1). The proliferation rate 
of the ASCs on PCSs increased gradually from days 1-7. The results 
indicate that the ASCs were able to attach and proliferate effectively 
on PCSs.   
  
 
Figure 1. ICC characterisation of ASCs: Isolated ASCs from adipose tissue 
were positively stained as follows: [A]. CD 29, [B].CD 90, [C]. CD 105 and 
[D]. CD 73. The morphology of the cells expressing the cell surface markers 
were captured under 100x magnification. 
 
Figure 2. Flow cytometric surface marker expression profile: The side scatter (SSC) and 
forward scatter (FSC) were adjusted accordingly to gate the population of interest. The 
gate P1 in the SSC vs. FSC plot, represents the experimental population of ASCs. The 
gate P2 is referred as the interval gate enclosing the positive cell population in each 
fluorescence parameter. The positive expression levels of cell surface markers in human 
ASCs were clearly shown in the figures: [A]. CD 90 (85%), [B]. CD 73 (89%), [C]. CD 
29 (85%) and Only35% of ASC population express [D]. CD 105. Also, ASCs were found 
to be negative for [E]. CD34 (8.8%). [F]. Isotype control IgG1. 
 
 
 Figure 3. Expression level of cell surface markers: This graph shows the 
percentage of cells expressing cell surface markers CD 90, CD 73, CD 29, CD 105, 
CD 34 and Isotype control. 
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 3.5 Observation of cell morphology by SEM 
 
The SEM analysis is shown in Figure 5. The PCSs were prepared as 
small discs that were 2 mm thick and 10 mm in diameter. (Figure 
5A) By SEM, the PCSs seemed to have a round or elongated oval 
shape with a pore diameter ranging from 39-78 µm. (Figure 5B) On 
day 1, only few cells were found to have adhered to the scaffold, and 
these cells had a spherical structural morphology. (Figure 5C) On 
day 3, the cells were found to have an extended cell structural 
morphology. (Figure 5D) After 7 days of proliferation of the ASCs 
on the PCSs, the cell numbers had significantly increased, and 
several of the cells showed fully extended spindle-shape-like 
morphology.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 Observation of cell morphology by H&E staining 
 
The ASCs were allowed to proliferate on PCSs for 7 days, and H&E 
staining was performed on the 7th day. The nuclei of the cells were 
stained with hematoxylin, which appeared purple-violet in color, 
whereas the chitosan scaffold appeared purple-red in color, as 
depicted in Figure 6. On  the 7th day, most of the cells had migrated 
from the surface of the scaffold to the interior pores of the scaffold, 
and they were found to be distributed uniformly throughout the PCS.   
 
 
Figure 5. Morphological observation of incorporated ASCs on PCS under SEM: [A]. PCS 
only without the ASCs (x600). The morphology of ASCs seeded on PCS following: [B]. 24 
hours of culture (x3000), [C]. 3 days of culture (x3000) and [D]. 7 days of culture ( x12000). 
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Figure 4. Induced differentiation of ASCs : Adipogenic induction of ASCs at 2 weeks is 
demonstrated by Oil Red O staining under [A].100x and [B]. 200x magnification. The 
arrow marks indicate the lipids present in adipocytes which appears red. Osteoblast 
detection was demonstrated by two types of staining. i.) Staining the Calcium deposits with 
alizarin red S: [C].Undifferentiated ASCs appeared in slightly reddish colour (10x 
magnification). [D]. Fully differentiated ASCs into osteoblasts appears in bright orange – 
red colour (100x magnification). ii.) AP staining for the detection of osteoblasts showing 
[E].Undifferentiated ASCs in faintly bluish colour (100x magnification) and [F]. Fully 
differentiated osteoblasts in black colour (100x magnification). Finally chondrogenic 
differentiation of ASCs is confirmed using Alcian staining. The cartilage extracellular 
matrix appears dark-blue [G]. at 2 weeks  and [H]. at 4 weeks after induction (100x 
magnification). 
 
DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7 
0.53±0.019 0.74±0.018 0.96±0.048 1.15±0.029 1.30±0.007 1.41±0.009 1.43±0.048 
 
Table 1. Absorbance at 570nm (mean±SEM, n=4): This figure shows the proliferation 
rate of ASCs analyzed using PrestoBlue viability assay. The results are presented as mean 
± standard error. The p- value from the Kruskal Wallis test is 0.004, which is less than 
0.05. Based on the mean ranks from the test, the proliferation rate of ASCs on day 7 is 
much higher compared to day 1. 
 
Figure 6.  Morphology of ASCs incorporated on PCS observed using H & E 
staining:  H & E staining on day 7 showed the distribution of ASCs in purple-violet 
colour and the PCS appears in purple-red colour (100x magnification). 
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4. Discussion 
 
Wound healing is a complex process that starts with an inflammatory 
phase, followed by re-epithelialization and remodeling phases[23]. In 
patients with extensive skin loss, complete recovery is often 
challenging because of a lack of efficient and effective tissue 
formation during the re-epithelialization phase, leaving disfiguring 
scars and muscle contractures. Tissue repair requires the migration 
and proliferation of cells that concertedly communicate with various 
types of neighboring cells to restore the tissue’s function.  
 
As conventional treatment strategies for treating chronic wounds often 
fails, over the last decade, stem cell-based therapies have been 
focused on overcoming the difficulties in tissue reconstruction. ASCs 
derived from subcutaneous adipose tissue are the most promising 
MSCs; these cells remain stable under normal cell culture conditions, 
involve less invasive procedures than bone marrow biopsies do and 
are cost effective. By using specific differentiation media, ASCs can 
be differentiated into various cell lineages, such as osteoblasts, 
chondrogenic ECM and adipocytes, to repair damaged cells in the 
bones or heart or to help to heal chronic ulcers[6. 24-26]. 
 
The cultured ASCs used in this study were plastic adherent under 
standard cell culture conditions. These cells’ phenotype was positive 
for the MSC markers CD90, CD73, CD29, and CD105 and negative 
for the hematopoietic stem cell marker CD34. Identification of the 
ASC surface immunophenotype is very important to identify and 
purify the stem cell population. ICC is the most common cell-staining 
technique and is used to localize the presence of a specific antigen in 
cells by using a specific primary antibody that binds to the antigen. 
An added chromogenic dye binds to this primary antibody-secondary 
antibody-streptavidin complex and converts it into a colored complex, 
thereby aiding visualization of the cells under a microscope. In the 
current study, the flow cytometry results revealed that more than 80% 
of ASCs expressed the cell surface markers CD90, CD73, and CD29, 
whereas CD105 was expressed by only 35% of the stem cell 
population. Although CD105 is an important marker for the 
characterization of MSCs, its expression varies depending on the 
passage of cells used[27-29]. 
 
Studies have shown that ASCs with low or negative expression of 
CD105 have a greater capacity to differentiate into adipogenic and 
osteogenic lineages[30, 31]. The present study clearly showed the 
expression levels of various markers using fluorescence-activated cell 
sorting (FACS) analysis and revealed ASCs’ capability to 
differentiate into adipogenic, osteogenic and chondrogenic lineages. 
The Oil Red O staining revealed lipid droplets in the cytoplasm of the 
ASCs and confirmed adipogenic induction. The AP staining and 
Alizarin Red S staining confirmed the osteogenic induction. The 
Alizarin Red S staining revealed the presence of irregular calcium salt 
deposits, stained red, and the AP staining revealed black particulate 
material. The chondrogenic induction was confirmed by Alcian-Blue 
staining and showed the presence of cartilage ECM, with a dark blue 
color. The adipogenic, osteogenic and chondrogenic differentiation of 
ASCs has several clinical applications. Autologous fat tissue graft 
transplantation is one of the best methods used for tissue 
reconstruction and plastic surgery. Tissue-engineered fat derived from 
adipose tissue is used for various reconstructive and cosmetic 
procedures, including augmentation of the breasts, lips and chin; 
rejuvenation of aging skin to treat wrinkles; repair of congenital 
deformities; and also treatment of chronic injuries resulting in soft 
tissue loss[32-34]. Studies have shown that the osteogenic 
differentiation of ASCs successfully contributed to bone formation in 
murine models [35] and that chondrogenic differentiation  can  be  used  
 
to generate cartilage for treating degenerative joints in osteoarthritis 
patients[26]. Although there are numerous advantages of ASCs, these 
cells still need an appropriate scaffold to act as an artificial ECM for 
cell attachment and proliferation. 
 
There are a number of biomaterials available, but selecting an 
appropriate scaffold for maximizing the proliferative and 
differentiative potential of ASCs is very crucial. In one study, it was 
demonstrated that ASCs derived from Sprague-Dawley rats exhibited 
greater adhesion and viability when seeded on silk fibroin-chitosan 
scaffolds[36]. Chitosan derived from the exoskeleton of arthropods 
has been most widely investigated in tissue engineering. There are 
various grades and derivatives of chitosan used for different clinical 
applications. Characterization of the different grades of chitosan was 
conducted in our previous study, and their structural properties were 
discussed[22]. Chitosan-agglomerated scaffolds were found to be 
excellent scaffolds for the induction of ASC differentiation and 
proliferation into osteogenic and chondrogenic cell lineages[37]. 
Studies have shown that when human hair follicle stem cells along 
with fibroblasts were seeded on chitosan scaffolds, these constructs 
were successful in accelerating the healing of full-thickness wounds 
in irradiated rats[38]. Although numerous studies have been carried 
out using different types of chitosan, the role of PCSs in the 
proliferation of ASCs has not been explored. This is the first study to 
ever evaluate the compatibility of PCSs with the attachment and 
proliferation of ASCs. ASCs with their greater proliferation capacity 
and PCSs as an excellent scaffold would play an important role in 
tissue engineering.  
 
The degree of deacetylation of chitosan used in the fabrication of 
PCS is greater than 70% and have a molecular weight of 6.34x105 
Daltons, that are capable of providing better surface- forming 
properties[19]. Studies have shown that the interconnected pores of a 
scaffold play an important role in tissue regeneration and also help to 
achieve greater, more uniform cell attachment and proliferation on 
the scaffold[39-41]. Thus, PCSs, with their porous structure, enable the 
accumulation and proliferation of a greater number of ASCs. In the 
current study, the ASCs exhibited greater adhesion starting from 24 
hrs after the ASCs were seeded on PCSs. On day 3, changes in the 
structure of the ASCs were noted, and on day 7, there was an 
increase in the cell number, and the ASCs had appropriate cellular 
morphology. The majority of the ASCs were found to have 
proliferated on the interior of the porous scaffold membrane. The 
H&E staining on the 7th day also showed a uniform distribution for a 
large number of ASCs across the PCSs. Supporting these results, the 
live/dead assay carried out on ASCs seeded on PCS scaffold, also 
revealed that the ASCs exhibited a great adhesion and viability on 
PCS in our previous study[42]. A statistically significant difference 
was observed in the PrestoBlue viability assay, indicating that the 
ASCs exhibited greater adhesion and proliferation starting from day 
1, and these parameters were found to have  increased on subsequent 
days, clearly demonstrating that higher proliferation of ASCs on 
PCSs was observed on day 7. 
 
In this study, ASCs were successfully isolated and characterized, and 
their multi-differentiation potential was also clearly demonstrated. 
PCSs, with their porous structure, were found to act as an excellent 
template for the ASCs to attach and proliferate. The viability test 
revealed that the ASCs seeded on the PCSs had an increased 
proliferation rate indicating that the PCSs are more compatible for 
the attachment and proliferation of ASCs. This study may lay the 
foundation for the further investigation of PCSs for tissue 
reconstruction in the field of skin tissue engineering. 
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